Opinion: FDA ‘rushing to judgement’ on BPA

Article in Environmental Health News discusses main goal of CLARITY-BPA program and U.S. FDA’s premature conclusions on BPA hazards

Webinar on CLARITY-BPA core study

U.S. Food and Drug Administration hosts webinar on guideline studies conducted within CLARITY-BPA program, September 13, 2018; registration now open

Webinar on CLARITY-BPA academic studies

Carnegie Mellon University holds webinar on independent academic studies on bisphenol A within CLARITY-BPA program, September 12, 2018; registration now open

Regulatory identification of BPA as endocrine disruptor

Special issue of Molecular and Cellular Endocrinology addresses regulatory identification of bisphenol A as endocrine disruptor, summarizes evidence for endocrine-mediated adverse effects on estrous cycle, mammary gland development, neurobehavior, metabolism

EFSA: Update on BPA reassessment

New working group of EFSA’s CEP Panel to commence evaluation of BPA hazard studies in September 2018; finalization of new BPA hazard assessment foreseen for 2020

OECD guideline on development toxicity updated

OECD adds endpoints to prenatal development toxicity testing guideline to better detect effects of endocrine disruptors

ACC: Myths and facts about food packaging

American Chemistry Council comments on American Academy of Pediatrics’ health concerns about food additives, claims ‘food packaging in the U.S. is best in class’

ECETOC annual report 2017

Annual report of European Centre for Ecotoxicology and Toxicology of Chemicals informs about activities on endocrine disruptors, polymers, risk assessment tools

Chemicals in plastics and obesity

U.S. researchers discuss contribution of exposure to endocrine disruptors to metabolic disorders such as obesity and diabetes

Chemical exposures during pregnancy

Washington Post discusses exposure to environmental chemicals during pregnancy, risks posed to unborn children